• 1

    WHO, 2004. The World Health Report. Geneva: World Health Organization.

  • 2

    Flu PC, 1911. Die aetiologie der in Surinam vorkommenden sogenannten “Boschyaws”, einer der Aleppobeule analogen Erkrankung. Centralbl Bakt Parasit Kde Orig 60 :624–637.

    • Search Google Scholar
    • Export Citation
  • 3

    Burgos A, Hudson J, 1994. Annotated list of the phlebotominae (diptera) of Suriname. Mem Inst Oswaldo Cruz 89 :171–178.

  • 4

    Wijers D, Linger R, 1966. Man-biting sandflies in Surinam (Dutch Guiana): Phlebotomus anduzei as a possible vector of Leishmania braziliensis. Ann Trop Med Parasitol 60 :501–508.

    • Search Google Scholar
    • Export Citation
  • 5

    Hudson J, Young DG, 1985. New records of phlebotomines, leishmaniasis and mosquitoes from Suriname. Trans R Soc Trop Med Hyg 79 :418.

  • 6

    Rotureau B, 2006. Ecology of the Leishmania species in the guianan ecoregion complex. Am J Trop Med Hyg 74 :81–96.

  • 7

    Lai A, Fat EJ, Vrede MA, Soetosenojo RM, Lai A, Fat RF, 2002. Pentamidine, the drug of choice for the treatment of cutaneous leishmaniasis in Surinam. Int J Dermatol 41 :796–800.

    • Search Google Scholar
    • Export Citation
  • 8

    Winckel W, Aalstein M, 1953. Contribution to the geographical pathology of Suriname: first case of kalaazar in Surinam. Doc Med Geogr Trop 5 :339–342.

    • Search Google Scholar
    • Export Citation
  • 9

    Herwaldt BL, 1999. Leishmaniasis. Lancet 354 :1191–1199.

  • 10

    Blum J, Desjeux P, Schwartz E, Beck B, Hatz C, 2004. Treatment of cutaneous leishmaniasis among travelers. J Antimicrob Chemother 53 :158–166.

    • Search Google Scholar
    • Export Citation
  • 11

    Rioux JA, Lanotte G, Serres E, Pratlong F, Bastien P, Perieres J, 1990. Taxonomy of Leishmania. Use of isoenzymes. Suggestions for a new classification. Ann Parasitol Hum Comp 65 :111–125.

    • Search Google Scholar
    • Export Citation
  • 12

    Garcia L, Kindt A, Bermudez H, Llanos-Cuentas A, De Doncker S, Arevalo J, Tintaya K, Dujardin J, 2004. Culture-independent species typing of neotropical Leishmania for clinical validation of a PCR-based assay targeting heat shock protein 70 genes. J Clin Microbiol 42 :2294–2297.

    • Search Google Scholar
    • Export Citation
  • 13

    Marfurt J, Nasereddin A, Niederwieser I, Jaffe C, Beck H, Felger I, 2003. Identification and differentiation of Leishmania species in clinical samples by PCR amplification of the miniexon sequence and subsequent restriction fragment length polymorphism analysis. J Clin Microbiol 41 :3147–3153.

    • Search Google Scholar
    • Export Citation
  • 14

    Schönian G, Nasereddin A, Dinse N, Schweynoch C, Schallig HDFH, Presber W, Jaffe CL, 2003. PCR diagnosis and characterization of Leishmania in local and imported clinical samples. Diagn Microbiol Infect Dis 47 :349–358.

    • Search Google Scholar
    • Export Citation
  • 15

    Desjeux P, 2004. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 27 :305–318.

  • 16

    van der Meide WF, Schoone GJ, Faber WR, Zeegelaar JE, de Vries HJ, Ozbel Y, Lai A, Fat RF, Coelho LI, Kassi M, Schallig HD, 2005. Quantitative nucleic acid sequence-based assay as a new molecular tool for the detection and quantification of Leishmania parasites in skin biopsies. J Clin Microbiol 43 :5560–5566.

    • Search Google Scholar
    • Export Citation
  • 17

    Rotureau B, Ravel C, Nacher M, Couppié P, Curtet I, Dedet J-P, Carme B, 2006. Molecular epidemiology of Leishmania (Viannia) guyanensis in French Guiana. J Clin Microbiol 44 :468–473.

    • Search Google Scholar
    • Export Citation
  • 18

    Convit J, Ulrich M, Fernandez CT, Tapia FJ, Caceres-Dittmar G, Castes M, Rondon AJ, 1993. The clinical and immunological spectrum of American cutaneous leishmaniasis. Trans R Soc Trop Med Hyg 87 :444–448.

    • Search Google Scholar
    • Export Citation
  • 19

    Esterre P, Chippaux JP, Lefait JF, Dedet JP, 1986. Evaluation of a cutaneous leishmaniasis control program in a forest village of French Guyana. Bull World Health Organ 64 :559–565.

    • Search Google Scholar
    • Export Citation
  • 20

    Rotureau B, Joubert M, Clyti E, Djossou F, Carme B, 2006. Leishmaniasis among gold miners, French Guiana. Emerg Infect Dis 12 :1169–1170.

    • Search Google Scholar
    • Export Citation
  • 21

    Copeland HW, Arana BA, Navin TR, 1990. Comparison of active and passive case detection of cutaneous leishmaniasis in Guatemala. Am J Trop Med Hyg 43 :257–259.

    • Search Google Scholar
    • Export Citation
  • 22

    Dedet J, Pradinaud R, Gay F, 1989. Epidemiological aspects of human cutaneous leishmaniasis in French Guiana. Trans R Soc Trop Med Hyg 83 :616–620.

    • Search Google Scholar
    • Export Citation
  • 23

    Chaves LF, Pascual M, 2006. Climate cycles and forecasts of cutaneous leishmaniasis, a nonstationary vector-borne disease. PLoS Medicine 3 :e295.

    • Search Google Scholar
    • Export Citation
  • 24

    Sutherst RW, 2004. Global change and human vulnerability to vector-borne diseases. Clin Microbiol Rev 17 :136–173.

  • 25

    Cardenas R, Sandoval CM, Rodriguez-Morales AJ, Franco-Paredes C, 2006. Impact of climate variability in the occurrence of leishmaniasis in northeastern Colombia. Am J Trop Med Hyg 75 :273–277.

    • Search Google Scholar
    • Export Citation
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 

 

 

Epidemiology of Cutaneous Leishmaniasis in Suriname: A Study Performed in 2006

View More View Less
  • 1 KIT Biomedical Research, Royal Tropical Institute, Amsterdam, The Netherlands; Department of Dermatology, Academic Medical Centre, Amsterdam, The Netherlands; Medical Mission, Primary Health Care Suriname, Paramaribo, Suriname; Department of Dermatology, Academic Hospital, Paramaribo, Suriname; Dermatology Service, Ministry of Health, Paramaribo, Suriname
Restricted access

Cutaneous leishmaniasis (CL) is a widespread disease in Suriname caused by Leishmania Viannia guyanensis. It is argued that other Leishmania species are also responsible for CL and that the incidence is increasing. This study aimed to identify the species causing the disease and to estimate the annual detection rate of CL in Suriname in 2006. In Paramaribo, 152 patients were registered, of whom 33 were tested in two polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP) methods. Twenty-seven patients were infected with L. (V.) guyanensis (complex), one with L. (V.) lainsoni, and one with L. (Leishmania) amazonensis. In the hinterland, 162 CL suspected patients were registered by questionnaires; of these, 24 of 27 tested positive by PCR-RFLP (88.9%; 95% CI, 77.1–100%). With extrapolation of collected data, a detection rate was calculated of 5.32 to 6.13 CL patients per 1,000 inhabitants for the hinterland and 0.64 to 0.74 patients per 1,000 inhabitants for the whole country.

Save